Balancing access to BPaLM regimens and risk of resistance.
Van Rie A, Walker T, de Jong B, Rupasinghe P, Rivière E, Dartois V, Sonnenkalb L, Machado D, Gagneux S, Supply P, Dreyer V, Niemann S, Goig G, Meehan C, Tagliani E, Cirillo DM.
Van Rie A, et al. Among authors: riviere e.
Lancet Infect Dis. 2022 Oct;22(10):1411-1412. doi: 10.1016/S1473-3099(22)00543-6. Epub 2022 Aug 22.
Lancet Infect Dis. 2022.
PMID: 36007529
No abstract available.